Prelude Capital Management, LLC Dexcom Inc Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

A detailed history of Prelude Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 15,189 shares of DXCM stock, worth $1.09 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

15,189

Previous 16,190 6.18%

Holding current value

$1.09 Million

Previous $2.25 Million 23.3%

% of portfolio

0.12%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $110,420 - $140,590	-1,001 Reduced 6.18%	15,189 $1.72 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $1.85 Million - $2.27 Million	16,190 New	16,190 $2.25 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $1.52 Million - $2.44 Million	17,664 New	17,664 $1.65 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $1.02 Million - $1.2 Million	-9,787 Reduced 76.03%	3,085 $358,000
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $184,576 - $266,439	-2,172 Reduced 14.44%	12,872 $1.46 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $28,631 - $35,317	-375 Reduced 2.43%	15,044 $1.21 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $688,466 - $1.35 Million	10,126 Added 191.31%	15,419 $1.15 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $353,082 - $488,640	3,753 Added 243.7%	5,293 $2.71 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $389 - $488	3 Added 0.2%	1,540 $827,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $164,013 - $220,067	1,537 New	1,537 $841,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $79,956 - $98,769	-943 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $66,222 - $88,720	-849 Reduced 47.38%	943 $349,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $45,940 - $54,328	481 Added 36.69%	1,792 $739,000
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $416,759 - $700,405	-6,649 Reduced 83.53%	1,311 $531,000
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $80,925 - $110,072	-2,883 Reduced 26.59%	7,960 $948,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $73,871 - $102,281	2,737 Added 33.77%	10,843 $1.3 Million
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $64,679 - $101,714	-2,770 Reduced 25.47%	8,106 $1.16 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $18,750 - $26,960	-1,069 Reduced 8.95%	10,876 $1.03 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $156,001 - $221,460	11,945 New	11,945 $886,000

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Dexcom Inc Transaction History